Despite these limitations, our study, with its large sample size, indicates that serum C4 can serve as a biomarker of kidney function deterioration in DKD, serum C3 as a biomarker of advanced DKD, and that there may be a synergistic effect between serum C4 and C3 in worsening kidney function in DKD. Here, C4A is linked to diabetic kidney disease.